APO Research
Talk to an analyst

APO RESEARCH · REPORT

Donepezil Hydrochloride Tablet

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Donepezil Hydrochloride Tablet Market Outlook and Growth Opportunities 2026

2 January 2026191 pages

Choose your research edition.

Industry ResearchDonepezil Hydrochloride Tablet Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Donepezil Hydrochloride Tablet Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Donepezil Hydrochloride Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Donepezil Hydrochloride Tablet Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Donepezil Hydrochloride Tablet Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Donepezil Hydrochloride Tablet market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Donepezil Hydrochloride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Donepezil Hydrochloride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Donepezil Hydrochloride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Donepezil Hydrochloride Tablet market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Donepezil Hydrochloride Tablet market include Eisai, Luoxin Pharmaceutical, Pfizer, Huahai Pharmaceutical, Hansoh Pharma, Hisun Pharmaceutical, ARK PHA.LTD, Lupin and Globalstar, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Donepezil Hydrochloride Tablet market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Donepezil Hydrochloride Tablet and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Donepezil Hydrochloride Tablet sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Donepezil Hydrochloride Tablet market size, projected growth trends, production technologies, key applications, and end-use industries.

Donepezil Hydrochloride Tablet Segment by Company

Eisai

Luoxin Pharmaceutical

Pfizer

Huahai Pharmaceutical

Hansoh Pharma

Hisun Pharmaceutical

ARK PHA.LTD

Lupin

Globalstar

G Med Impex

Donepezil Hydrochloride Tablet Segment by Type

5 mg/tablet

10 mg/tablet

Donepezil Hydrochloride Tablet Segment by Application

Hospitals

Drugstores

Others

Donepezil Hydrochloride Tablet Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Donepezil Hydrochloride Tablet status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Donepezil Hydrochloride Tablet market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Donepezil Hydrochloride Tablet significant trends, drivers, influence factors in global and regions.

6. To analyze Donepezil Hydrochloride Tablet competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Donepezil Hydrochloride Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Donepezil Hydrochloride Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Donepezil Hydrochloride Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Donepezil Hydrochloride Tablet market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Donepezil Hydrochloride Tablet industry.

Chapter 3: Detailed analysis of Donepezil Hydrochloride Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Donepezil Hydrochloride Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Donepezil Hydrochloride Tablet in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Donepezil Hydrochloride Tablet Industry Trends Table 2. Donepezil Hydrochloride Tablet Industry Drivers Table 3. Donepezil Hydrochloride Tablet Industry Opportunities and Challenges Table 4. Donepezil Hydrochloride Tablet Industry Restraints Table 5. Global Donepezil Hydrochloride Tablet Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Donepezil Hydrochloride Tablet Revenue Share by Company (2021-2026) Table 7. Global Donepezil Hydrochloride Tablet Sales Volume by Company (K Pcs) & (2021-2026) Table 8. Global Donepezil Hydrochloride Tablet Sales Volume Share by Company (2021-2026) Table 9. Global Donepezil Hydrochloride Tablet Average Price (US$/Pcs) of Company (2021-2026) Table 10. Global Donepezil Hydrochloride Tablet Company Ranking, (2024-2026) & (USD Million) Table 11. Global Donepezil Hydrochloride Tablet Key Company Manufacturing Base & Headquarters Table 12. Global Donepezil Hydrochloride Tablet Company, Product Type & Application Table 13. Global Donepezil Hydrochloride Tablet Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Donepezil Hydrochloride Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 5 mg/tablet Table 18. Significant Companies of 10 mg/tablet Table 19. Global Donepezil Hydrochloride Tablet Sales Volume by Type 2021 VS 2025 VS 2032 (K Pcs) Table 20. Global Donepezil Hydrochloride Tablet Sales Volume by Type (2021-2026) & (K Pcs) Table 21. Global Donepezil Hydrochloride Tablet Sales Volume by Type (2027-2032) & (K Pcs) Table 22. Global Donepezil Hydrochloride Tablet Sales Volume Share by Type (2021-2026) Table 23. Global Donepezil Hydrochloride Tablet Sales Volume Share by Type (2027-2032) Table 24. Global Donepezil Hydrochloride Tablet Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Donepezil Hydrochloride Tablet Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Donepezil Hydrochloride Tablet Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Donepezil Hydrochloride Tablet Sales Value Share by Type (2021-2026) Table 28. Global Donepezil Hydrochloride Tablet Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospitals Table 30. Significant Companies of Drugstores Table 31. Significant Companies of Others Table 32. Global Donepezil Hydrochloride Tablet Sales Volume by Application 2021 VS 2025 VS 2032 (K Pcs) Table 33. Global Donepezil Hydrochloride Tablet Sales Volume by Application (2021-2026) & (K Pcs) Table 34. Global Donepezil Hydrochloride Tablet Sales Volume by Application (2027-2032) & (K Pcs) Table 35. Global Donepezil Hydrochloride Tablet Sales Volume Share by Application (2021-2026) Table 36. Global Donepezil Hydrochloride Tablet Sales Volume Share by Application (2027-2032) Table 37. Global Donepezil Hydrochloride Tablet Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Donepezil Hydrochloride Tablet Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Donepezil Hydrochloride Tablet Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Donepezil Hydrochloride Tablet Sales Value Share by Application (2021-2026) Table 41. Global Donepezil Hydrochloride Tablet Sales Value Share by Application (2027-2032) Table 42. Global Donepezil Hydrochloride Tablet Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Table 43. Global Donepezil Hydrochloride Tablet Sales by Region (2021-2026) & (K Pcs) Table 44. Global Donepezil Hydrochloride Tablet Sales Market Share by Region (2021-2026) Table 45. Global Donepezil Hydrochloride Tablet Sales by Region (2027-2032) & (K Pcs) Table 46. Global Donepezil Hydrochloride Tablet Sales Market Share by Region (2027-2032) Table 47. Global Donepezil Hydrochloride Tablet Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Donepezil Hydrochloride Tablet Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Donepezil Hydrochloride Tablet Sales Value Share by Region (2021-2026) Table 50. Global Donepezil Hydrochloride Tablet Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Donepezil Hydrochloride Tablet Sales Value Share by Region (2027-2032) Table 52. Global Donepezil Hydrochloride Tablet Market Average Price (US$/Pcs) by Region (2021-2026) Table 53. Global Donepezil Hydrochloride Tablet Market Average Price (US$/Pcs) by Region (2027-2032) Table 54. Global Donepezil Hydrochloride Tablet Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 55. Global Donepezil Hydrochloride Tablet Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Donepezil Hydrochloride Tablet Sales by Country (2021-2026) & (K Pcs) Table 57. Global Donepezil Hydrochloride Tablet Sales Market Share by Country (2021-2026) Table 58. Global Donepezil Hydrochloride Tablet Sales by Country (2027-2032) & (K Pcs) Table 59. Global Donepezil Hydrochloride Tablet Sales Market Share by Country (2027-2032) Table 60. Global Donepezil Hydrochloride Tablet Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Donepezil Hydrochloride Tablet Sales Value Market Share by Country (2021-2026) Table 62. Global Donepezil Hydrochloride Tablet Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Donepezil Hydrochloride Tablet Sales Value Market Share by Country (2027-2032) Table 64. Eisai Company Information Table 65. Eisai Business Overview Table 66. Eisai Donepezil Hydrochloride Tablet Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 67. Eisai Donepezil Hydrochloride Tablet Product Portfolio Table 68. Eisai Recent Development Table 69. Luoxin Pharmaceutical Company Information Table 70. Luoxin Pharmaceutical Business Overview Table 71. Luoxin Pharmaceutical Donepezil Hydrochloride Tablet Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 72. Luoxin Pharmaceutical Donepezil Hydrochloride Tablet Product Portfolio Table 73. Luoxin Pharmaceutical Recent Development Table 74. Pfizer Company Information Table 75. Pfizer Business Overview Table 76. Pfizer Donepezil Hydrochloride Tablet Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 77. Pfizer Donepezil Hydrochloride Tablet Product Portfolio Table 78. Pfizer Recent Development Table 79. Huahai Pharmaceutical Company Information Table 80. Huahai Pharmaceutical Business Overview Table 81. Huahai Pharmaceutical Donepezil Hydrochloride Tablet Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 82. Huahai Pharmaceutical Donepezil Hydrochloride Tablet Product Portfolio Table 83. Huahai Pharmaceutical Recent Development Table 84. Hansoh Pharma Company Information Table 85. Hansoh Pharma Business Overview Table 86. Hansoh Pharma Donepezil Hydrochloride Tablet Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 87. Hansoh Pharma Donepezil Hydrochloride Tablet Product Portfolio Table 88. Hansoh Pharma Recent Development Table 89. Hisun Pharmaceutical Company Information Table 90. Hisun Pharmaceutical Business Overview Table 91. Hisun Pharmaceutical Donepezil Hydrochloride Tablet Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 92. Hisun Pharmaceutical Donepezil Hydrochloride Tablet Product Portfolio Table 93. Hisun Pharmaceutical Recent Development Table 94. ARK PHA.LTD Company Information Table 95. ARK PHA.LTD Business Overview Table 96. ARK PHA.LTD Donepezil Hydrochloride Tablet Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 97. ARK PHA.LTD Donepezil Hydrochloride Tablet Product Portfolio Table 98. ARK PHA.LTD Recent Development Table 99. Lupin Company Information Table 100. Lupin Business Overview Table 101. Lupin Donepezil Hydrochloride Tablet Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 102. Lupin Donepezil Hydrochloride Tablet Product Portfolio Table 103. Lupin Recent Development Table 104. Globalstar Company Information Table 105. Globalstar Business Overview Table 106. Globalstar Donepezil Hydrochloride Tablet Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 107. Globalstar Donepezil Hydrochloride Tablet Product Portfolio Table 108. Globalstar Recent Development Table 109. G Med Impex Company Information Table 110. G Med Impex Business Overview Table 111. G Med Impex Donepezil Hydrochloride Tablet Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 112. G Med Impex Donepezil Hydrochloride Tablet Product Portfolio Table 113. G Med Impex Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Donepezil Hydrochloride Tablet Distributors List Table 117. Donepezil Hydrochloride Tablet Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Donepezil Hydrochloride Tablet Product Image Figure 2. Global Donepezil Hydrochloride Tablet Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Donepezil Hydrochloride Tablet Sales Value (2021-2032) & (US$ Million) Figure 4. Global Donepezil Hydrochloride Tablet Sales (2021-2032) & (K Pcs) Figure 5. Global Donepezil Hydrochloride Tablet Sales Average Price (US$/Pcs) & (2021-2032) Figure 6. Global Donepezil Hydrochloride Tablet Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 5 mg/tablet Image Figure 10. 10 mg/tablet Image Figure 11. Global Donepezil Hydrochloride Tablet Sales Volume by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 12. Global Donepezil Hydrochloride Tablet Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Donepezil Hydrochloride Tablet Sales Volume Share by Type (2021-2032) Figure 14. Global Donepezil Hydrochloride Tablet Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Donepezil Hydrochloride Tablet Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Donepezil Hydrochloride Tablet Sales Value Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Drugstores Image Figure 19. Others Image Figure 20. Global Donepezil Hydrochloride Tablet Sales Volume by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 21. Global Donepezil Hydrochloride Tablet Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Donepezil Hydrochloride Tablet Sales Volume Share by Application (2021-2032) Figure 23. Global Donepezil Hydrochloride Tablet Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Donepezil Hydrochloride Tablet Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Donepezil Hydrochloride Tablet Sales Value Share by Application (2021-2032) Figure 26. Global Donepezil Hydrochloride Tablet Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Figure 27. Global Donepezil Hydrochloride Tablet Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Donepezil Hydrochloride Tablet Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Donepezil Hydrochloride Tablet Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Donepezil Hydrochloride Tablet Sales Value (2021-2032) & (US$ Million) Figure 31. North America Donepezil Hydrochloride Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Donepezil Hydrochloride Tablet Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Donepezil Hydrochloride Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Donepezil Hydrochloride Tablet Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Donepezil Hydrochloride Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Donepezil Hydrochloride Tablet Sales Value (2021-2032) & (US$ Million) Figure 37. South America Donepezil Hydrochloride Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Donepezil Hydrochloride Tablet Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Donepezil Hydrochloride Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Donepezil Hydrochloride Tablet Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Donepezil Hydrochloride Tablet Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 5 mg/tablet
  • 10 mg/tablet
Applications
  • Hospitals
  • Drugstores
  • Others
Companies covered
  • Eisai
  • Luoxin Pharmaceutical
  • Pfizer
  • Huahai Pharmaceutical
  • Hansoh Pharma
  • Hisun Pharmaceutical
  • ARK PHA.LTD
  • Lupin
  • Globalstar
  • G Med Impex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Donepezil Hydrochloride Tablet Sales Value (2021-2032)
  4. 1.2.2 Global Donepezil Hydrochloride Tablet Sales Volume (2021-2032)
  5. 1.2.3 Global Donepezil Hydrochloride Tablet Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Donepezil Hydrochloride Tablet Market Dynamics
  1. 2.1 Donepezil Hydrochloride Tablet Industry Trends
  2. 2.2 Donepezil Hydrochloride Tablet Industry Drivers
  3. 2.3 Donepezil Hydrochloride Tablet Industry Opportunities and Challenges
  4. 2.4 Donepezil Hydrochloride Tablet Industry Restraints
3 Donepezil Hydrochloride Tablet Market by Company
  1. 3.1 Global Donepezil Hydrochloride Tablet Company Revenue Ranking in 2025
  2. 3.2 Global Donepezil Hydrochloride Tablet Revenue by Company (2021-2026)
  3. 3.3 Global Donepezil Hydrochloride Tablet Sales Volume by Company (2021-2026)
  4. 3.4 Global Donepezil Hydrochloride Tablet Average Price by Company (2021-2026)
  5. 3.5 Global Donepezil Hydrochloride Tablet Company Ranking (2024-2026)
  6. 3.6 Global Donepezil Hydrochloride Tablet Company Manufacturing Base and Headquarters
  7. 3.7 Global Donepezil Hydrochloride Tablet Company Product Type and Application
  8. 3.8 Global Donepezil Hydrochloride Tablet Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Donepezil Hydrochloride Tablet Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Donepezil Hydrochloride Tablet Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Donepezil Hydrochloride Tablet Market by Type
  1. 4.1 Donepezil Hydrochloride Tablet Type Introduction
  2. 4.1.1 5 mg/tablet
  3. 4.1.2 10 mg/tablet
  4. 4.2 Global Donepezil Hydrochloride Tablet Sales Volume by Type
  5. 4.2.1 Global Donepezil Hydrochloride Tablet Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Donepezil Hydrochloride Tablet Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Donepezil Hydrochloride Tablet Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Donepezil Hydrochloride Tablet Sales Value by Type
  9. 4.3.1 Global Donepezil Hydrochloride Tablet Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Donepezil Hydrochloride Tablet Sales Value by Type (2021-2032)
  11. 4.3.3 Global Donepezil Hydrochloride Tablet Sales Value Share by Type (2021-2032)
5 Donepezil Hydrochloride Tablet Market by Application
  1. 5.1 Donepezil Hydrochloride Tablet Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Drugstores
  4. 5.1.3 Others
  5. 5.2 Global Donepezil Hydrochloride Tablet Sales Volume by Application
  6. 5.2.1 Global Donepezil Hydrochloride Tablet Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Donepezil Hydrochloride Tablet Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Donepezil Hydrochloride Tablet Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Donepezil Hydrochloride Tablet Sales Value by Application
  10. 5.3.1 Global Donepezil Hydrochloride Tablet Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Donepezil Hydrochloride Tablet Sales Value by Application (2021-2032)
  12. 5.3.3 Global Donepezil Hydrochloride Tablet Sales Value Share by Application (2021-2032)
6 Donepezil Hydrochloride Tablet Regional Sales and Value Analysis
  1. 6.1 Global Donepezil Hydrochloride Tablet Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Donepezil Hydrochloride Tablet Sales by Region (2021-2032)
  3. 6.2.1 Global Donepezil Hydrochloride Tablet Sales by Region: 2021-2026
  4. 6.2.2 Global Donepezil Hydrochloride Tablet Sales by Region (2027-2032)
  5. 6.3 Global Donepezil Hydrochloride Tablet Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Donepezil Hydrochloride Tablet Sales Value by Region (2021-2032)
  7. 6.4.1 Global Donepezil Hydrochloride Tablet Sales Value by Region: 2021-2026
  8. 6.4.2 Global Donepezil Hydrochloride Tablet Sales Value by Region (2027-2032)
  9. 6.5 Global Donepezil Hydrochloride Tablet Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Donepezil Hydrochloride Tablet Sales Value (2021-2032)
  12. 6.6.2 North America Donepezil Hydrochloride Tablet Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Donepezil Hydrochloride Tablet Sales Value (2021-2032)
  15. 6.7.2 Europe Donepezil Hydrochloride Tablet Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Donepezil Hydrochloride Tablet Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Donepezil Hydrochloride Tablet Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Donepezil Hydrochloride Tablet Sales Value (2021-2032)
  21. 6.9.2 South America Donepezil Hydrochloride Tablet Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Donepezil Hydrochloride Tablet Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Donepezil Hydrochloride Tablet Sales Value Share by Country, 2025 VS 2032
7 Donepezil Hydrochloride Tablet Country-level Sales and Value Analysis
  1. 7.1 Global Donepezil Hydrochloride Tablet Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Donepezil Hydrochloride Tablet Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Donepezil Hydrochloride Tablet Sales by Country (2021-2032)
  4. 7.3.1 Global Donepezil Hydrochloride Tablet Sales by Country (2021-2026)
  5. 7.3.2 Global Donepezil Hydrochloride Tablet Sales by Country (2027-2032)
  6. 7.4 Global Donepezil Hydrochloride Tablet Sales Value by Country (2021-2032)
  7. 7.4.1 Global Donepezil Hydrochloride Tablet Sales Value by Country (2021-2026)
  8. 7.4.2 Global Donepezil Hydrochloride Tablet Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Donepezil Hydrochloride Tablet Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Donepezil Hydrochloride Tablet Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Donepezil Hydrochloride Tablet Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eisai
  2. 8.1.1 Eisai Company Information
  3. 8.1.2 Eisai Business Overview
  4. 8.1.3 Eisai Donepezil Hydrochloride Tablet Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Eisai Donepezil Hydrochloride Tablet Product Portfolio
  6. 8.1.5 Eisai Recent Developments
  7. 8.2 Luoxin Pharmaceutical
  8. 8.2.1 Luoxin Pharmaceutical Company Information
  9. 8.2.2 Luoxin Pharmaceutical Business Overview
  10. 8.2.3 Luoxin Pharmaceutical Donepezil Hydrochloride Tablet Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Luoxin Pharmaceutical Donepezil Hydrochloride Tablet Product Portfolio
  12. 8.2.5 Luoxin Pharmaceutical Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Donepezil Hydrochloride Tablet Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Donepezil Hydrochloride Tablet Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Huahai Pharmaceutical
  20. 8.4.1 Huahai Pharmaceutical Company Information
  21. 8.4.2 Huahai Pharmaceutical Business Overview
  22. 8.4.3 Huahai Pharmaceutical Donepezil Hydrochloride Tablet Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Huahai Pharmaceutical Donepezil Hydrochloride Tablet Product Portfolio
  24. 8.4.5 Huahai Pharmaceutical Recent Developments
  25. 8.5 Hansoh Pharma
  26. 8.5.1 Hansoh Pharma Company Information
  27. 8.5.2 Hansoh Pharma Business Overview
  28. 8.5.3 Hansoh Pharma Donepezil Hydrochloride Tablet Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hansoh Pharma Donepezil Hydrochloride Tablet Product Portfolio
  30. 8.5.5 Hansoh Pharma Recent Developments
  31. 8.6 Hisun Pharmaceutical
  32. 8.6.1 Hisun Pharmaceutical Company Information
  33. 8.6.2 Hisun Pharmaceutical Business Overview
  34. 8.6.3 Hisun Pharmaceutical Donepezil Hydrochloride Tablet Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hisun Pharmaceutical Donepezil Hydrochloride Tablet Product Portfolio
  36. 8.6.5 Hisun Pharmaceutical Recent Developments
  37. 8.7 ARK PHA.LTD
  38. 8.7.1 ARK PHA.LTD Company Information
  39. 8.7.2 ARK PHA.LTD Business Overview
  40. 8.7.3 ARK PHA.LTD Donepezil Hydrochloride Tablet Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 ARK PHA.LTD Donepezil Hydrochloride Tablet Product Portfolio
  42. 8.7.5 ARK PHA.LTD Recent Developments
  43. 8.8 Lupin
  44. 8.8.1 Lupin Company Information
  45. 8.8.2 Lupin Business Overview
  46. 8.8.3 Lupin Donepezil Hydrochloride Tablet Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Lupin Donepezil Hydrochloride Tablet Product Portfolio
  48. 8.8.5 Lupin Recent Developments
  49. 8.9 Globalstar
  50. 8.9.1 Globalstar Company Information
  51. 8.9.2 Globalstar Business Overview
  52. 8.9.3 Globalstar Donepezil Hydrochloride Tablet Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Globalstar Donepezil Hydrochloride Tablet Product Portfolio
  54. 8.9.5 Globalstar Recent Developments
  55. 8.10 G Med Impex
  56. 8.10.1 G Med Impex Company Information
  57. 8.10.2 G Med Impex Business Overview
  58. 8.10.3 G Med Impex Donepezil Hydrochloride Tablet Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 G Med Impex Donepezil Hydrochloride Tablet Product Portfolio
  60. 8.10.5 G Med Impex Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Donepezil Hydrochloride Tablet Value Chain Analysis
  2. 9.1.1 Donepezil Hydrochloride Tablet Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Donepezil Hydrochloride Tablet Sales Mode & Process
  6. 9.2 Donepezil Hydrochloride Tablet Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Donepezil Hydrochloride Tablet Distributors
  9. 9.2.3 Donepezil Hydrochloride Tablet Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst